BusinessSorrento Therapeutics CEO Dr. Henry Ji Invited to the Fourth International Vatican Conference on “Unite to Cure”By Nasdaq OMXApr 23, 2018, 12:01 PM UTC
BusinessVineti Completes $33.5 Million in Series B Financing to Accelerate Patient Access to Cell and Gene TherapiesBy Nasdaq OMXApr 16, 2018, 11:30 AM UTC
BusinessSorrento Therapeutics Welcomes Jiong Shao as Chief Financial Officer and Reaffirms Intent to Seek Nasdaq/HKSE Dual Listing in 2018By Nasdaq OMXMar 19, 2018, 12:00 PM UTC
BusinessPoseida Therapeutics Presents Stem Cell Memory CAR-T Therapy for Prostate Cancer at 2018 Keystone Symposia on Emerging Cellular TherapiesBy Nasdaq OMXFeb 14, 2018, 1:01 PM UTC
BusinessPoseida Therapeutics Appoints Martin Giedlin, Ph.D., as Vice President, Technical OperationsBy Nasdaq OMXFeb 5, 2018, 1:01 PM UTC
BusinessCellular Biomedicine Group Plans Grand Opening of its New Shanghai FacilityBy Nasdaq OMXSep 22, 2017, 12:40 PM UTC
BusinessCellular Biomedicine Group to Present at the Cantor Fitzgerald Global Healthcare ConferenceBy Nasdaq OMXSep 14, 2017, 12:30 PM UTC
BusinessVineti expands its platform to support provision of American Red Cross allogeneic apheresis collections for cellular therapyBy Nasdaq OMXSep 6, 2017, 1:01 PM UTC
